These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8735227)

  • 1. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
    Augood SJ; Faull RL; Love DR; Emson PC
    Neuroscience; 1996 Jun; 72(4):1023-36. PubMed ID: 8735227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.
    Norris PJ; Waldvogel HJ; Faull RL; Love DR; Emson PC
    Neuroscience; 1996 Jun; 72(4):1037-47. PubMed ID: 8735228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study.
    Augood SJ; Westmore K; Emson PC
    Neuroscience; 1997 Feb; 76(3):763-74. PubMed ID: 9135049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
    Menalled L; Zanjani H; MacKenzie L; Koppel A; Carpenter E; Zeitlin S; Chesselet MF
    Exp Neurol; 2000 Apr; 162(2):328-42. PubMed ID: 10739639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
    Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
    Jolkkonen J; Jenner P; Marsden CD
    Brain Res Mol Brain Res; 1995 Sep; 32(2):297-307. PubMed ID: 7500841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
    Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
    Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
    Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
    Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
    Nisenbaum LK; Kitai ST; Gerfen CR
    Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
    Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
    Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
    Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
    Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion.
    Nisenbaum LK; Kitai ST; Crowley WR; Gerfen CR
    Neuroscience; 1994 Jun; 60(4):927-37. PubMed ID: 7523989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. delta-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen.
    Mailleux P; Vanderhaeghen JJ
    Eur J Pharmacol; 1994 Mar; 267(1):R1-3. PubMed ID: 7515821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
    Bordelon YM; Chesselet MF
    Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis.
    Hurd YL; Herkenham M
    Neuroscience; 1995 Feb; 64(3):571-86. PubMed ID: 7536307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat.
    Johansson B; Lindström K; Fredholm BB
    Neuroscience; 1994 Apr; 59(4):837-49. PubMed ID: 7520134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
    Emson PC; Arregui A; Clement-Jones V; Sandberg BE; Rossor M
    Brain Res; 1980 Oct; 199(1):147-60. PubMed ID: 6157454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.